66 Best Hormone Therapy Doctors Abroad

Dr. Napat Jirattitikarntavorn focuses on facial aesthetics and regenerative therapy at Menness Wellness Clinic in Bangkok. He specializes in non-surgical facial design using Botox, fillers, and thread lifts. Dr. Napat also integrates longevity treatments like hormone balancing and IV therapy into his anti-aging protocols.

• Performs liquid facelifts and jawline contouring using hyaluronic acid fillers.
• Treats hair loss and skin aging with Platelet-Rich Plasma (PRP) therapy.
• Manages metabolic health through gut health programs and detox protocols.
• Works at a clinic accredited by the Royal College of Surgeons Thailand.

Dr. Fatih Yanaral is a urology and robotic surgery specialist at Memorial Şişli Hospital. He has authored 43 academic works and six book chapters in his field. Dr. Yanaral completed specialized training in reconstructive urology at Hamburg-Eppendorf University Hospital in Germany.

• Serves as an editor for The New Journal of Urology.
• Participated in over 100 medical congresses as a speaker or attendee.
• Is a member of the European Association of Urology.
• Works at the first JCI-accredited hospital in Turkey.

Expert in personalized hormone therapy with a focus on genomic profiling – Dr. Raphael leads groundbreaking clinical trials at Sourasky Medical Center.

• Senior Lecturer with extensive experience in medical oncology
• Leader of Israel's national Genomic Medicine Initiative (PSIFAS)
• Primary investigator for multiple immunotherapy clinical trials
• European Society of Medical Oncology (ESMO) member
• Recipient of multiple teaching excellence awards from Tel-Aviv University

Dr. Pelles Sharon specializes in hormone therapy at Sourasky Medical Center (Ichilov), with notable contributions to clinical research on cancer treatments.

• Highly respected oncologist with extensive experience
• Conducted research on oncologic patients' attitudes towards clinical trials
• Provides a wide range of cancer treatments including hormone therapy
• Works at a leading medical center in Israel

Dr. Sarid specializes in hormone therapy for various cancers, combining chemotherapy, radiotherapy, and biological treatments at Sourasky Medical Center.

• Senior oncologist at Sourasky since 2009
• Trained in cancer urology at Oxford University
• Principal investigator in clinical trials for cancer therapies
• Member of ESMO and ASCO
• Lecturer at Tel Aviv University

Professor Ofer Merimsky leads the Soft Tissue and Bone Oncology Unit at Sourasky Medical Center with decades of specialized expertise.

• Over 41 years experience in hormone therapy and sarcoma treatment
• Senior investigator at Weizmann Institute and Sackler Faculty of Medicine
• Member of ESMO Sarcoma group faculty
• Pioneering research collaborations in tumor immunology

Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.

Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.

Leads 2 provincial S&T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.

Professor Kim Jong-yeon is a gastroenterologist at Myongji Hospital. He treats diseases of the esophagus, stomach, colon, and liver, including cirrhosis and hepatitis. He performs therapeutic endoscopy, such as endoscopic polypectomy. He also serves as Deputy Director of the International Healthcare Center.

He is a member of the Liver Failure Center. He works with teams in hepatology, liver cancer, and transplantation to provide coordinated care for advanced liver disease and for transplant candidates.

MD, Jeonbuk National University College of Medicine. Clinical Professor of Gastroenterology at Myongji Hospital. Member of the Korean Association of Internal Medicine, the Korean Society of Gastroenterology, and the Korean Society of Gastrointestinal Endoscopy. Former resident and fellow at Inje University Ilsan Paik Hospital.

Dr. He Weibing is a pioneer of argon-helium cryoablation in China with more than 20 years of frontline practice. He was a founding member of Fuda Cancer Hospital (Guangzhou). He co-founded its Minimally Invasive Tumor Treatment Center and served as Executive Deputy Director. He also helped found the Ablation Group of the China Anti-Cancer Association. He has been the primary operator in more than 10,000 procedures.

He specializes in tumor cryoablation and is proficient in 125I seed brachytherapy, with a focus on liver and lung cancers. He proposed ten argon-helium techniques. Key co-authored data include: lung cryotherapy n=508; NSCLC n=120 (CR 25.5%, PR 41.8%, 6/12/24-month survival 64%/55%/36%); pancreatic cancer n=38 (median survival 12 months). He served on editorial boards in 2008 and 2010. He has been a national trainer for Varian and Boston Scientific since 2001.

Professor Luo Xiaoping is a nationally recognized interventional radiologist and a leading authority in Western China. He began pioneering vascular interventions in the early 1990s. He helped found the Interventional Group at the Second Affiliated Hospital of Chongqing Medical University.

He has completed over 100,000 interventional procedures, including about 4,000 complex cases. His key skills include TACE for hepatocellular carcinoma, Budd–Chiari interventions, TIPS, and single-stage bilateral stenting for hilar biliary obstruction, with success rates near 100%. He has been a master’s supervisor since 2007. He has trained many physicians, guided complex cases at more than 40 major hospitals across Western China, and helped build interventional programs. He has published 32 papers as first or corresponding author (22 CSCD core, 4 Chinese core, 6 CSCD extended).

Dr. Mehmet Salih Iyikesici is a medical oncologist. His work focuses on metabolically supported chemotherapy (MSCT), ketogenic diet–supported cancer care, hyperthermia, hyperbaric oxygen therapy, and insulin potentiation therapy. He emphasizes care for breast, pancreatic, and gastric cancers.

He is a Medical Oncology Specialist at Neolife Medical Center (2026–present). He previously served at Private Bahçelievler Medical Park (2013–2026), Medicana Beylikdüzü (2010–2013), Silivri Anadolu (2009–2010), Diyarbakır Training and Research (2008–2009), and Bursa Çekirge State (2006–2008). Earlier, he worked as an Internal Medicine Specialist (1997–2003). He was an Assistant Professor at Altınbaş University (2014–2026).

Training: Medical Oncology subspecialty, Marmara University (2003–2006). Internal Medicine, Istanbul Haydarpaşa Numune (1992–1996). Medicine, Uludağ University (1985–1990). Member, Medical Oncology Association (since 2004). His recent research (2019–2020) covers gastric, breast, pancreatic, and lung cancers. Topics include long‑term survival in metastatic pancreatic cancer and feasibility in metastatic non‑small cell lung cancer (NSCLC).

Dr. Einat Shacham Shmueli is a senior medical oncologist at Sheba Medical Center. She specializes in gastrointestinal cancers, treating the colon, stomach, and pancreas. Dr. Shacham Shmueli holds dual board certifications in oncology and gastroenterology. She trained at UCSF in the United States. Her clinic at Sheba Medical Center is ranked among the top 10 hospitals worldwide.

• Authored over 25 peer-reviewed publications on tumor biology and new treatments.
• Serves as an investigator for the National Cancer Institute (NCI) programs.
• Manages metastatic disease using precision diagnostics and specialized biomarkers.
• Member of the Israel Society of Oncology and Radiotherapy.

Dr. Yuri Goldes is the Deputy Director of General Surgery at Sheba Medical Center. He pioneered some of Israel’s first robotic resections for stomach and pancreatic cancers. Forbes Israel named him among the nation’s best gastrointestinal surgeons. In 2019, he received the Best Doctor of the Year award from the Israeli Ministry of Health.

• Specializes in robotic and laparoscopic surgery for pancreatic, gastric, and esophageal cancers.
• Performs minimally invasive Whipple procedures, one of the most complex abdominal operations.
• Treats benign conditions including diaphragmatic hernia, achalasia, GERD, and gallbladder disease.
• Works at Sheba Medical Center, ranked among the Top 10 hospitals worldwide by Newsweek.

Professor Xiao Yueyong is Chief Physician in the Department of Radiological Diagnosis at the Chinese PLA General Hospital. He is a leading expert in minimally invasive interventional oncology. He serves as the inaugural President of WATA (2025–). He is President of the International (2020–) and Asian (2012–) Societies of Cryotherapy. He is also Deputy Head of the NHC Expert Group on tumour ablation regulations (2009–).

He has performed over 100,000 CT/MRI‑guided minimally invasive procedures. His work covers chemical ablation, RFA, MWA, cryoablation, and NanoKnife (IRE). He introduced and advanced NanoKnife ablation in China. He led the first national standards for tumour cryoablation and NanoKnife.

Honors include the National Special Contribution Award (Lifetime Honorary). He received First Prize from the Chinese Medicine Education Association (2021). He received two Second Prizes for Military Medical Achievements (2016, 2018) and two Second Prizes from the China Anti‑Cancer Association (2019, 2022). He was named Asian Ablation Master. His research record includes 13 Chinese patents. He is the principal investigator for four NSFC projects and one MOST subject. He has published over 200 papers, with over 110 as first or corresponding author and over 40 in SCI journals. He has led over 10 ablation guidelines or consensus statements.

Dr. Suleyman Hilmi Ipekci is a professor of endocrinology at Atlas University. He treats complex hormone disorders, thyroid cancers, and pituitary diseases. He practices at Hisar Hospital Intercontinental in Istanbul. This JCI-accredited facility serves over 500,000 patients annually. Dr. Ipekci earned his medical degree and residency at Istanbul University.

• Authored over 40 articles in international journals with 230 citations.
• Winner of multiple awards at the National Diabetes Congress.
• Led scientific projects funded by TUBITAK, Turkey's national research council.
• Focuses on diabetes and adrenal gland management for international patients.

Dr. Wanna Supasirilak is an aesthetic doctor at Wansiri Hospital in Bangkok. She specializes in regenerative medicine and anti-aging therapies. Her practice focuses on hormone treatments and nutritional wellness. She earned her medical degree from Chulalongkorn University. Dr. Supasirilak holds multiple diplomas from the American Academy of Anti-aging Medicine.

• Certified by the American Board of Anti-aging and Regenerative Medicine.
• Holds a diploma from the American Board of Nutritional Wellness.
• Practices at Wansiri Hospital, which reports a 99% success rate for plastic surgery.
• Trained in stem cell applications for aesthetics and hormone therapies.

The doctor is a highly experienced Obstetrics and Gynaecology Specialist with a robust clinical background spanning several major medical institutions in Turkey. Currently practicing at Memorial Bahçelievler Hospital since 2022, the doctor has previously served in key clinical roles at Bezmialem Foundation University Faculty of Medicine Hospital and Kahta State Hospital.

Throughout a career dedicated to women's health, the doctor has focused on providing comprehensive obstetric and gynecological care, managing complex clinical cases, and maintaining high standards of patient treatment within both university hospital settings and state medical facilities.

Fellowship-trained at Hacettepe University Cancer Institute – Dr. Solak specializes in hormone therapy for multiple cancer types.

• Deals with breast, testicular, ovarian, and lung cancers
• Residency at Istanbul Sisli Etfal Training Hospital
• Trained at The University of Texas MD Anderson Cancer Center
• Expert in gastrointestinal and head-neck cancers

The doctor specializes in oncology and gastroenterology, offering extensive expertise in diagnosing and treating complex cancers and gastrointestinal disorders. With a focus on innovative treatment plans, the doctor has contributed to numerous clinical trials and research studies, advancing the field of oncology. The doctor is board-certified and has published several peer-reviewed articles in leading medical journals. The doctor is committed to providing personalized patient care and has been recognized for excellence in clinical practice.

Professor Yesim Yildirim specializes in cancer immunotherapy and targeted therapies, with over 80 publications in medical oncology.

• Member of European Society of Medical Oncology (ESMO)
• Expert in breast, gastrointestinal, and lung cancers
• Professor at Halic University, Istanbul
• Completed advanced training in Melanoma and Kidney Cancer Clinic in London